unknown
Stage
2021
Founded
1
Investors
About
Corteria Pharmaceuticals is a privately held biotechnology company developing first-in-class drugs, focused on interceptive therapies for worsening and acute decompensated heart failure and related subpopulations such as sarcopenia and obesity. The company emphasizes innovative patient stratification and target selection to address high unmet medical needs in cardiovascular indications.
Explore Corteria Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.